STATISTICAL COMPARISONS OF GYNECOLOGIC CANCER AGE GROUPS IN THE OB-GYN DEPARTMENT OF THE ARAD COUNTY HOSPITAL DURING THE 2000-2004 PERIOD

This is an automatically generated default intro template – please do not edit.

	Read full article
Article Title:	STATISTICAL COMPARISONS OF GYNECOLOGIC CANCER AGE GROUPS IN THE OB-GYN DEPARTMENT OF THE ARAD COUNTY HOSPITAL DURING THE 2000-2004 PERIOD
Authors:	Daşcău Voicu1*, Furău Gheorghe1, Păiuşan Lucian2, Radu Adriana2, Furău Cristian1, Para Cristina3, Stănescu Casiana4, Onel Cristina1, Ulgut Corina5
Affiliation:	1”Vasile Goldiş” Western University of Arad, Faculty of Medicine, Ob-Gyn Department, Romania 2”Vasile Goldiş” Western University of Arad, Faculty of Medicine, Anatomopathology Department, Romania 3”Vasile Goldiş” Western University of Arad, Faculty of Medicine, Internal Medicine Department, Romania 4”Vasile Goldiş” Western University of Arad, Faculty of Medicine, Anatomy Department, Romania 5Clinical County Emergency Hospital, Anatomopathology Department, Arad, Romania
Abstract:	The purpose of this study is to statistically compare the mean ages of the patients with gynecologic cancer in our hospital during the 2000-2004 interval. The data was collected from the Histopathology Exams (HPE) registers. During the five year period, a number of 619 gynecological cancers were diagnosed in our hospital by the anatomopathology department: 367 cervical cancers (59.29%), 191 uterine cancers (30.86%), 50 ovarian cancers (8.08%), and 11 vulvar cancers (1.78%); the histological specimens were obtained from biopsies and/or surgery. The mean ages were 53.66±13.29 years for cervical cancer (age range 23-86 years), 61.41±8.82 years for uterine cancer (age range 38-82 years), 54.44±13.84 years for ovarian cancer (age range 21-77 years); vulvar cancer (age range 53-77 years) did not have a normal distribution of the cases. The age groups with the most patients were: 41-50 years for cervical cancer (104 cases or 28.34%), 51-60 years for uterine cancer (81 cases or 42.41%), 51-60 and 61-70 years for ovarian cancer (14 cases or 28% each), and 61-70 years for vulvar cancer (4 cases or 36.36%). After performing Student’s test, the statistically significant difference was cervical cancer vs uterine cancer(p<0.05). The mean ages of different cancer types in uor study are similar to those in literature.
Keywords:	cervical cancer, uterine cancer, vulvar cancer, ovarian cancer, vaginal cancer, statistical significance, Student’s t-test
References:	Beller U, Benedet J, Creasman W, et al. Carcinoma of the vagina. Int J Gynaecol Obstet 2006;95 Suppl 1:S29. Beller U, Benedet JL, Creasman WT, Ngan HYS, Quinn MA, Maisonneuve P, et al. Carcinoma of the vagina: 26th Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 2006;95:S29-S42 Beller U, Quinn M, Benedet J, et al. Carcinoma of the vulva. Int J Gynaecol Obstet 2006;95(Suppl 1):S7-S27. Burke TW, Levenback C, Tornos C, et al. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996;62:169. Creasman WT, Odicino F, Mausinneuve P, Quinn MA, Beller U, Benedet JL et al. Carcinoma of the corpus uteri. FIGO Annual Report, Vol 26. Int J Gynaecol Obstet 2006;95(suppl 1):S105-S143. Guerriero S, Alcazar JL, Pascual MA, Ajossa S, Olartecoechea B, Hereter L. The pre-operative diagnosis of metastatic ovarian tumors is related to the origin of the primary tumor. Ultrasound Obstet Gynecol. 2011 Oct 13. doi: 10.1002/uog.10120. (Epub ahead of print) Heintz APM, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman W, et al. Carcinoma of the ovary. Int J Gynecol Obstet 2003;83(suppl 1):135-166. http://seer.cancer.gov/csr/1975_2008/results_single/sect_01_table.11_2pgs.pdf http://seer.cancer.gov/statfacts/html/cervix.html http://seer.cancer.gov/statfacts/html/corp.html http://seer.cancer.gov/statfacts/html/ovary.html http://seer.cancer.gov/statfacts/html/vulva.html http://www.cancer.gov/cancertopics/pdq/treatment/vaginal/Patient Huang CY, You SL, Chen CJ, Cheng WF, Luo HC, Hsieh CY Incidence of cervical cancer and age-specific survival of small cell cervical carcinoma in Taiwan. Acta Obstet Gynecol Scand. 2011 Dec;90(12):1342-1349 Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43. Klaus H. Baumann, Olga Müller, Helke B. Naujok, Ellen Mann, Peter Barth, and Uwe Wagner Small-Area Analysis of Incidence and Localisation of Vulvar Cancer Journal of Oncology Volume 2010 (2010), Article ID 512032 Kondi-Pafiti A, Kairi-Vasilatou E, Iavazzo C, Dastamani C, Bakalianou K, Liapis A, Hassiakos D, Fotiou S. Metastatic neoplasms of the ovaries: a clinicopathological study of 97 cases. Arch Gynecol Obstet. 2011 Nov;284(5):1283-8 Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden Globocan 2000, Int J Cancer 2001;94:153-156. Shepherd J, Sideri M, Benedet J, et al. Carcinoma of the vulva. J Epidemiol Biostat 1998;3:111. Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, Tao XG. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer. 2008 Nov 15;113(10 Suppl):2873-82.
*Correspondence:	drdascauvoicu@yahoo.com